M. Curlo
University of Parma
Internal medicineEndocrinologySurgeryOutcome (game theory)Natural historyRandomized controlled trialReceptorDiverticular diseaseGastrinGERDGastric acidDiverticulitisCurcuminTest (assessment)AgonistDiseaseMesalazineAtrophic gastritisGastro-esophageal reflux diseaseDomperidonCOLONIC DIVERTICULAR DISEASEUncomplicated diverticular diseaseFollow up studiesIn patientLong term treatmentIncidence (epidemiology)SerologySecretionClinical trialGeneral surgeryMedicineGastroenterologyPharmacology
28Publications
2H-index
62Citations
Publications 28
Newest
#1Luigi Gatta (University of Parma)H-Index: 29
#2Francesco Di Mario (University of Parma)H-Index: 41
Last. Carmelo Scarpignato (University of Parma)H-Index: 48
view all 10 authors...
The aim of this work was to compare the recurrence of diverticulitis during a 5-year follow-up in a population of patients affected by symptomatic uncomplicated diverticular disease (SUDD), taking either 800 mg of mesalamine b.i.d for 10 days every month or no 5-ASA. Sixty-seven consecutive patients affected by SUDD followed-up every 6 months for 5 years. All patients in this group (M-group) were requested to consume mesalamine 800 mg b.i.d for 10 days every month. A control group (C-group) of 8...
Source
#1Francesco Di MarioH-Index: 41
#2Luigi GattaH-Index: 29
Last. Angelo FranzèH-Index: 21
view all 16 authors...
Source
#1P. SorianiH-Index: 1
Last. F. Di MarioH-Index: 32
view all 13 authors...
Source
#1M. CurloH-Index: 2
#2Luigi GattaH-Index: 29
Last. F. Di MarioH-Index: 32
view all 12 authors...
Source
#1Luigi GattaH-Index: 29
#2M. CurloH-Index: 2
Last. Francesco Di MarioH-Index: 41
view all 12 authors...
Source
#1M. CurloH-Index: 2
#2Luigi GattaH-Index: 29
Last. Francesco Di MarioH-Index: 41
view all 10 authors...
Source
#1Francesco Di MarioH-Index: 41
#2Luigi GattaH-Index: 29
Last. Angelo FranzèH-Index: 21
view all 13 authors...
Source
#1M. CurloH-Index: 2
#2Luigi GattaH-Index: 29
Last. Francesco Di MarioH-Index: 41
view all 11 authors...
Source
#1A. IoriH-Index: 1
#2Roberta MinelliH-Index: 22
Last. F. Di MarioH-Index: 32
view all 15 authors...
s / Digestive and Liver Disease 42S (2010) S61–S192 S113 (ITT) analysis, respectively; 3) Eradication rate in the CLA-ST group was 62/73 (84.9%) and 62/75(82.6%) in the PP and ITT analysis, respectively; 4) The difference in the eradication rate between LEV-ST and CLA-ST was statistically significant (p<0.001) by χ2 test in both PP and ITT analysis; 5) No significant differences in the incidence of adverse events was observed. Conclusions: This study indicates that in an area of high prevalence ...
Source
#1Luigi Gatta (UNIBO: University of Bologna)H-Index: 29
#2N. Vakil (UNIBO: University of Bologna)H-Index: 29
Last. Francesco Di Mario (University of Parma)H-Index: 41
view all 11 authors...
Objective To assess the therapeutic efficacy of 5-aminosalicylic acid (5-ASA) in patients with colonic diverticular disease performing a systematic review of the literature. Data Sources Cochrane Trial Register (until Issue 4, 2008), Medical Literature Analysis and Retrieval System Online (1966 to October 1, 2008), Excerpta Medica Database (1980 to October 1, 2008), and abstracts from the major US, European, and Asian gastroenterology conferences. Expert opinions sought and reference lists of id...
Source
This website uses cookies.
We use cookies to improve your online experience. By continuing to use our website we assume you agree to the placement of these cookies.
To learn more, you can find in our Privacy Policy.